(Q37244697)

19 August 2017

1 reference

title

Myelodysplastic syndrome: an update on diagnosis and therapy (English)

1 reference

19 August 2017

main subject

myelodysplastic syndrome

1 reference

Ahrin Koppel

1 reference

19 August 2017

Gary Schiller

series ordinal

1 reference

19 August 2017

publication date

1 September 2008

1 reference

19 August 2017

published in

Current Oncology Reports

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

19 August 2017

page(s)

372-378

1 reference

Proposals for the classification of the myelodysplastic syndromes

19 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-008-0058-Z

Rheumatic manifestations of the myelodysplastic syndromes: a comparative study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-008-0058-Z

Chronic myelomonocytic leukemia: natural history and prognostic determinants

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-008-0058-Z

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

21 January 2018

1 reference

12 December 2020

Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow

1 reference

12 December 2020

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

12 December 2020

Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes

1 reference

12 December 2020

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

1 reference

12 December 2020

HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome

1 reference

12 December 2020

The evolution of thalidomide and its IMiD derivatives as anticancer agents

1 reference

12 December 2020

Hypermethylation of the p15INK4B gene in myelodysplastic syndromes

1 reference

12 December 2020

Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes

1 reference

12 December 2020

Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and

1 reference

12 December 2020

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

1 reference

12 December 2020

Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia

1 reference

12 December 2020

Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy

1 reference

12 December 2020

Immune-mediated complications in patients with myelodysplastic syndromes--clinical and cytogenetic features

1 reference

12 December 2020

Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study

1 reference

12 December 2020

Cytogenetic aspects of adult primary myelodysplastic syndromes: clinical implications

1 reference

12 December 2020

Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome

1 reference

12 December 2020

DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: clinical results and possible mechanisms of action

1 reference

12 December 2020

1 reference

12 December 2020

Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment

1 reference

12 December 2020

Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression

1 reference

12 December 2020

Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score.

1 reference

12 December 2020

Report of an international working group to standardize response criteria for myelodysplastic syndromes.

1 reference

12 December 2020

Chromosomal alterations associated with evolution from myelodysplastic syndrome to acute myeloid leukemia

1 reference

12 December 2020

The 5q- syndrome: a single-institution study of 43 consecutive patients.

1 reference

12 December 2020

Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS.

1 reference

12 December 2020

Bone marrow histology and CD34 immunostaining in the prognostic evaluation of primary myelodysplastic syndromes

1 reference

12 December 2020

The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups

1 reference

12 December 2020

Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival

1 reference

12 December 2020

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

12 December 2020

Decitabine in myelodysplastic syndromes

1 reference

12 December 2020

The role of low-dose cytosine arabinoside and aggressive chemotherapy in advanced myelodysplastic syndromes

1 reference

12 December 2020

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

1 reference

12 December 2020

Modifying the epigenome as a therapeutic strategy in myelodysplasia

1 reference

12 December 2020

Acute febrile neutrophilic dermatosis (Sweet's syndrome) in association with myelodysplastic syndromes: a report of three cases and a review of the literature

1 reference

12 December 2020

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

1 reference

12 December 2020

International scoring system for evaluating prognosis in myelodysplastic syndromes

1 reference

12 December 2020

Efficacy of lenalidomide in myelodysplastic syndromes

1 reference

12 December 2020

Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statistics

1 reference

12 December 2020

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

1 reference

12 December 2020

Gene silencing in cancer in association with promoter hypermethylation

1 reference

12 December 2020

Diagnostic value of histology and immunohistochemistry in myelodysplastic syndromes.

1 reference

12 December 2020

French registry of acute leukemia and myelodysplastic syndromes. Age distribution and hemogram analysis of the 4496 cases recorded during 1982-1983 and classified according to FAB criteria. Groupe Francais de Morphologie Hematologique

1 reference

12 December 2020

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

1 reference

12 December 2020

10.1007/S11912-008-0058-Z

Identifiers

DOI

1 reference

19 August 2017

1 reference